Healthcare

https://techpapersworld.com/wp-content/uploads/2024/08/Invenio-Imaging-Announces-First-1280x720.jpg

HealthcareInvenio Imaging Announces First Patients Enrolled in US Pivotal Study of AI-Based Image Analysis Module for Lung Cancer

Invenio Imaging, a leader in intraoperative fresh tissue imaging and artificial intelligence (AI), announced today the enrollment of the first patients in a US pivotal study of its AI-based image analysis module for lung cancer. The ON-SITE study, a multicenter study in bronchoscopy combining Stimulated Raman Histology with Artificial Intelligence for rapid lung cancer detection, is in collaboration with Johnson & Johnson Enterprise Innovation Inc. and will be conducted at multiple centers including The University of Texas MD Anderson...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/08/Skanray-Partners-with-Tata-Elxsi-1280x720.jpg

HealthcareSkanray Partners with Tata Elxsi to Advance Surgical Imaging and Healthcare Innovation

Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, has chosen Tata Elxsi as a strategic partner for advanced surgical imaging core technology and software platform development. This collaboration aims to revolutionise diagnosis and treatment by leveraging cutting-edge technology modules, making them predictable, accurate, and consistent. Skanray is actively pursuing a long-term strategy to expand its portfolio by including new device families and modalities. This initiative...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/08/MCHOSE-Unveils-Its-First-Quick-Disassembly-1280x720.jpg

HealthcareImmunovia files US patent application to protect its next-generation test

Immunovia (Nasdaq Stockholm: IMMNOV), the pancreatic cancer diagnostics company, today announces the company has filed a US provisional patent application to protect the intellectual property embodied in its next-generation test to detect stage 1 and 2 pancreatic cancer. The patent application claims methods of diagnosing pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer. The company is seeking patent protection for the unique combination of five specific biomarkers used in its test, as...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/07/Axiom-Human-Genotyping-1280x720.png

HealthcareAxiom Human Genotyping Arrays Now Integrated with Allelica Polygenic Risk Score Software and Reports

Allelica, Inc., a leading provider of software tools for polygenic risk scores (PRS), announced a collaboration with Thermo Fisher Scientific, the world leader in serving science, to utilize Allelica’s bioinformatics software with Thermo Fisher’s Axiom™ Human Genotyping Microarrays to provide end-to-end solutions for genomics research customers. The genetic research and medical communities are gaining interest in PRS for disease risk prediction of common diseases and clinical trial patient stratification. PRS quantifies the total risk of specific diseases...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/07/PureHealth-Achieves-AED-1.0-billion-1280x720.png

HealthcarePureHealth Achieves AED 1.0 billion Net Profit in 1H 2024; EBITDA Soars to AED 2.2 billion

PureHealth Holding PJSC (‘PureHealth‘ or ‘the Group‘) (ADX Symbol: PUREHEALTH), the largest healthcare platform in the Middle East, today announced its financial results for the period ended 30 June 2024. PureHealth recorded a strong revenue increase of 53% y-o-y to AED 12.5 billion in H1 2024 on the back of solid growth booked across the majority of its verticals, primarily from the Hospitals, Insurance and Procurement segments. Commenting on the results, the Group’s Chairman, Hamad Al Hammadi, said: “PureHealth remains committed...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/07/DEEP-Launches-a-Platform-1280x720.jpg

HealthcareDEEP Launches a Platform to Build Digital Measures of Health

DEEP Measures announces its collaborative platform to build digital measures in clinical trials, boosting the second digital revolution of the 50 billion USD clinical research market. Twenty years ago, the industry started to collect clinical data with digital systems. Today, DEEP will facilitate the creation of precision digital measures, enabling direct capture of clinical data anywhere, any time. This offers a whole new perspective into human health and better understanding of how diseases and interventions impact people in their daily lives....

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/07/Implantica-announces-excellent--1280x720.jpg

HealthcareImplantica announces excellent RefluxStop™ investigator initiated study results published in Scientific Reports, a Nature journal

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces the independent study ‘Multicentric short term and safety study of ineffective esophageal motility (IEM) patients treated with RefluxStop device’ was recently published in Nature Scientific Reports. This investigator-initiated independent multicenter study was conducted at the General Hospital of the Medical University of Vienna, Austria, and King Edward VII Hospital in London, UK, from 2021 through 2023. All 40 patients had Ineffective...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/07/AliveDx-Receives-IVDR-CE-Mark-for-1280x720.jpg

HealthcareAliveDx Receives IVDR CE Mark for Groundbreaking Microarray Immunoassay in Allergy Diagnostics

AliveDx (“Company”) is proud to announce it has received IVDR CE mark for its groundbreaking microarray immunoassay, designed for the detection of a specific IgE directed to a protein allergen in human serum. This is the Company’s first product for the evaluation of allergies, enhancing its portfolio of products beyond autoimmunity. This immunoassay, run on AliveDx’s proprietary MosaiQ® platform, is an important milestone for the current development of the Company’s multiplex immunoassay microarray, which aims...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/07/XRP-Healthcare-Secures-Major-1280x720.jpg

HealthcareXRP Healthcare Secures Major Media Partnership with Global Exhibition Titans

XRP Healthcare is proud to announce a strategic partnership with two renowned global exhibition organizations, ACE Group and Genesis Global Exhibitions. This collaboration will establish ACE Group and Genesis Global Exhibitions as the official media partners for XRP Healthcare and XRP Healthcare Magazine until July 2025. This landmark partnership ensures enhanced visibility and engagement for XRP Healthcare and its magazine at key global events where investors and healthcare communities converge. With this collaboration, XRP Healthcare aims to strengthen its presence and influence in the international healthcare...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/07/The-Caris-Precision-Oncology-1280x720.jpg

HealthcareThe Caris Precision Oncology Alliance Welcomes The University of Mississippi Medical Center

Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today that The University of Mississippi Medical Center (UMMC) has joined the Caris Precision Oncology Alliance™ (Caris POA). The Caris POA is a growing network of leading cancer centers and research consortia across the globe that collaborate to advance precision oncology and biomarker-driven research, with its members working together to establish and optimize standards of care for molecular testing through innovative research to improve clinical...

Newer Posts

Older Posts